BioCentury
ARTICLE | Company News

ProEthic sales and marketing update

October 8, 2007 7:00 AM UTC

ProEthic launched Lipofen ( CIP-fenofibrate) in the U.S. to treat hyperlipidemia. ProEthic has exclusive rights to market the gelatin capsule containing fenofibrate in the U.S. from Cipher Pharmaceu...